Advertisement

Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions – Third Meeting

Virtual Event Virtual Event

This is the third meeting of the committee of experts and will be conducted virtually. The meeting will include a closed and public session. There will be an opportunity for interested stakeholders to share public comments with the committee on February 7, 2024 at 12:00 p.m. Public comments will provide the committee with additional insight

What’s Next for the Pandemic Financing Agenda?

Virtual Event Virtual Event

A virtual event featuring an expert panel focused on What's Next for the Pandemic Financing Agenda? will be held 7 February 2024. As the world approaches the four-year anniversary of the start of the COVID-19 pandemic, questions remain as to whether we are more prepared and ready than before. A recently published CGD working paper

Enhancing Biotechnology Innovation and Applications for National Security – First Meeting of Experts

National Academies of Sciences 2101 Constitution Ave NW, Washington, DC, United States
Virtual Event Hybrid Event

The National Academies will convene a meeting of experts on 8 Feb 2024 to focus on ways to foster a research and development network in the United States that drives biotechnology innovation and applications. This meeting will be held in a hybrid setting (Washington DC and online). This is the first of a series of

Why Indoor Chemistry Matters Prioritizing Indoor Chemistry Research – Workshop 2

National Academies of Sciences 2101 Constitution Ave NW, Washington, DC, United States
Virtual Event Hybrid Event

A National Academies committee of experts on Emerging Science on Indoor Chemistry will meet for a workshop on 8 February 2024 to discuss ways to support and prioritize indoor chemistry research. The event is a hybrid in-person (Washington DC) and virtual format. This event aims to discuss the following topics: Outcomes and recommendations from the

Forum on Medical and Public Health Preparedness for Disasters and Emergencies

Virtual Event Virtual Event

The Forum on Medical and Public Health Preparedness for Disasters and Emergencies will convene again on 15 February 2024. In this meeting, Forum members will: Identify the seminal social and behavioral sciences (SBS) lessons learned from COVID-19 and other past public health emergencies Explore how SBS lessons, concepts, and theories can be leveraged to inform

The Clear and Present Threat of Chem-Bio and Data and Cyberscientific and Technological (CB-DCST) Tools and Techniques

Virtual Event Virtual Event

The Homeland Defense & Security Information Analysis Center (HDIAC) will host a webinar on The Clear and Present Threat of Chem-Bio and Data and Cyberscientific and Technological (CB-DCST) Tools and Techniques on 15 February 2024. Given the current global shift toward symmetrical warfare, major powers and nonstate proxies are developing radical leveling and emerging technology

CWMD/MCDC Winter Medical & WMD Countermeasure Symposium

Baltimore Marriott Waterfront 700 Aliceanna St, Baltimore, MD, United States

The CWMD/MCDC: 2024 Winter Medical & WMD Countermeasure Symposium will be held 20-21 February 2024 in Baltimore, Maryland. Hosted by the Countering Weapons of Mass Destruction Consortium (CWMD) and the Medical CBRN Defense Consortium (MCDC), the event will feature sessions to interact with leads from key programs, for example: JPEO Futures Joint Project Leads (JPL)

The 38th Annual AAAI Conference on Artificial Intelligence

Vancouver Convention Center 1055 Canada Pl, Vancouver, British Columbia, Canada

The AAAI-24 Annual Conference on Artificial Intelligence will be held 20-27 February in Vancouver, Canada. The purpose of the AAAI conference series is to promote research in Artificial Intelligence (AI) and foster scientific exchange between researchers, practitioners, scientists, students, and engineers across the entirety of AI and its affiliated disciplines. AAAI-24 will feature technical paper

CIABT and Biological Risks

Palais des Nations 1211 Geneva 10, Geneva, Switzerland

Advances in biotechnology generate new opportunities, but also create certain risks in terms of dual use of biological and toxin agents and with respect to compliance with the 1972 Convention on the Prohibition of Biological Weapons (CIABT). This is the first event in a series of French-speaking meetings on disarmament in 2024 which will present